Table 7.

The Efficacy of Terazosin, Finasteride, or Both for Benign Prostatic Hyperplasia^*

	Change in	Change in
Agent	AUA Symptom Score	Qmax (mL/s)
Placebo	−2.6	+1.4
Finasteride	−3.2	+1.6
Terazosin	−6.1	+2.7
Finasteride + terazosin	−6.2	+3.2

^*1-year trial (N = 1229) comparing terazosin, 10 mg/d; finasteride, 5 mg/d; finasteride plus terazosin; and placebo.

AUA, American Urological Association; Q_max, peak urinary flow rate.

Data from Lepor H et al. N Eng J Med. 1996;335:533–539.⁹